Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas

被引:23
|
作者
Lazareff, JA [1 ]
Olmstead, C [1 ]
Bockhorst, KHJ [1 ]
Alger, JR [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL SCI,LOS ANGELES,CA 90095
关键词
astrocytoma; brain tumor; spectroscopy;
D O I
10.1007/BF00266813
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite their uniform histologic appearance, pediatric low-grade astrocytomas (LGA) often exhibit a rather unpredictable clinical course. It is presently unclear whether certain specific genetic, immunologic and/or metabolic features underlie these observed variations. In order to address this question we examined the tumor distribution of choline compounds (Cho), creatine (Cr) and N-acetyl aspartate (NAA) in seven children with midline LCA by means of proton magnetic resonance spectroscopy imaging (H-MRSI). Studies were performed with a 1.5 T GE Signa Scanner equipped with the standard head coil; nominal voxel size was 7.5 x 7.5 x 15 mm. This spatial resolution allowed us to select and independently evaluate multiple regions of interest (ROI) in the tumor as well as in areas of normal brain from the same individual. Normalized values of the observed signal intensities demonstrated a lower NAA and Cr content in the tumors than in the surrounding normal brain. Intratumoral Cho signals were also below normal values in all but one patient. The average Cho:NAA ratio was consistently higher in the tumor than in the normal brain. However, there was a wide variation (up to fourfold) in the Cho:NAA ratios of different ROIs, even within the same tumor. Our results clearly indicate that pediatric LGAs are metabolically heterogeneous, a feature that may be relevant to the understanding of their variable biologic behavior. Inasmuch as unique metabolic patterns were observed in some LGAs, we believe that systematic HMRSI studies of these patients may help define subsets within the group with specific therapeutic requirements.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 50 条
  • [2] Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas
    Porto, Luciana
    Kieslich, Matthias
    Franz, Kea
    Lehrbecher, Thomas
    Pilatus, Ulrich
    Hattingen, Elke
    BRAIN TUMOR PATHOLOGY, 2010, 27 (02) : 65 - 70
  • [3] Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas
    Luciana Porto
    Matthias Kieslich
    Kea Franz
    Thomas Lehrbecher
    Ulrich Pilatus
    Elke Hattingen
    Brain Tumor Pathology, 2010, 27 : 65 - 70
  • [4] Pediatric low-grade gliomas: Prognosis with proton magnetic resonance spectroscopic imaging
    Lazareff, JA
    Bockhorst, KHJ
    Curran, J
    Olmstead, C
    Alger, JR
    NEUROSURGERY, 1998, 43 (04) : 809 - 817
  • [6] Conformal proton radiation therapy for pediatric low-grade astrocytomas
    Hug, EB
    Muenter, MW
    Archambeau, JO
    DeVries, A
    Liwnicz, B
    Loredo, LN
    Grove, RI
    Slater, JD
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (01) : 10 - 17
  • [7] Conformal Proton Radiation Therapy for Pediatric Low-Grade Astrocytomas
    Eugen B. Hug
    Marc W. Muenter
    John O. Archambeau
    Alexander DeVries
    Boleslaw Liwnicz
    Lilia N. Loredo
    Roger I. Grove
    Jerry D. Slater
    Strahlentherapie und Onkologie, 2002, 178 : 10 - 17
  • [8] Cytogenetics in pediatric low-grade astrocytomas
    Orr, LC
    Fleitz, J
    McGavran, L
    Wyatt-Ashmead, J
    Handler, M
    Foreman, NK
    MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (03): : 173 - 177
  • [9] Mid-Treatment Magnetic Resonance Imaging in Pediatric Intracranial Low-Grade Gliomas Treated With Proton Beam Therapy
    Sreeraman, R.
    Vern-Gross, T.
    Indelicato, D. J.
    Bradley, J.
    Huh, S.
    Rotondo, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S725 - S725
  • [10] Mid-treatment magnetic resonance imaging in pediatric intracranial low-grade gliomas treated with proton beam therapy
    Kumar, Radhika Sreeraman
    Rotondo, Ronny L.
    Bradley, Julie A.
    Vern-Gross, Tamara
    Huh, Soon
    Indelicato, Daniel J.
    ACTA ONCOLOGICA, 2017, 56 (09) : 1243 - 1247